Low-dose IL-2 improved clinical symptoms by restoring reduced regulatory T cells in patients with refractory rheumatoid arthritis: A randomized controlled trial
Article in Frontiers in Immunology (November 2022)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (November 2022)
Article in European Medical Journal (May 2022)
Article in Translational Lung Cancer Research (June 2021)